中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Viral Diseases
NASH/PBC
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Goldman Sachs Invests US$20 Million in Ascletis
2015-12-03
Dr. Jinzi Wu was Invited to Speak at 11th Annual Gates Foundation Grand Challenges Conference
2015-10-19
Ascletis Secures US$35 Million Financing
2015-09-02
Ascletis Initiates Phase II Clinical Trial of Its Interferon-Free HCV Regimen in Taiwan
2015-08-31
Ascletis as the First Chinese Company to File Clinical Applications for Interferon-Free HCV Treatment
2015-06-24
HCV RACE IN CHINA
2015-04-13
Ascletis’ triple therapy HCV drug nails phase II trial in Chinese patients
2015-03-23
浙公网安备 33010802003344号
浙ICP备11050387号-1
